Beacon Financial Advisory
CVS icon

Beacon Financial Advisory’s CVS Health CVS Stock Holding History

Beacon Financial Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,321
Closed -$240K – 428
2026
Q2 		$240K Buy
+2,321
New +$207K 0.05% 381
2025
Q1 		– Sell
-14,088
Closed -$632K – 330
2024
Q4 		$632K Buy
14,088
+600
+4% +$33.7K 0.21% 136
2024
Q3 		$848K Sell
13,488
-238
-2% -$13.9K 0.29% 96
2024
Q2 		$811K Buy
13,726
+1,916
+16% +$120K 0.3% 91
2024
Q1 		$942K Buy
+11,810
New +$902K 0.46% 59
2022
Q2 		– Sell
-2,118
Closed -$214K – 225
2022
Q1 		$214K Buy
2,118
+1
+0% +$105 0.1% 223
2021
Q4 		$218K Buy
+2,117
New +$196K 0.1% 225
2020
Q3 		– Sell
-4,292
Closed -$278K – 178
2020
Q2 		$278K Sell
4,292
-94
-2% -$5.92K 0.3% 109
2020
Q1 		$260K Buy
+4,386
New +$293K 0.33% 105

Other funds holding CVS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Beacon Financial Advisory's CVS Position: Q3 2026 in Review

Beacon Financial Advisory sold out of CVS Health (CVS) in Q3 2026, closing a stake of 2,321 shares — an estimated $240K sold.

Beacon Financial Advisory first reported a position in CVS in Q1 2020 and held it in 9 quarters. The position peaked at $942K in Q1 2024. 1,724 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Beacon Financial Advisory reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
  • Beacon Financial Advisory sold 2,321 CVS Health shares in Q3 2026, an estimated $240K.
  • Beacon Financial Advisory first reported a position in CVS Health in Q1 2020 and held it in 9 quarters.
  • Beacon Financial Advisory's CVS Health position peaked at $942K in Q1 2024.
  • 1,724 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Beacon Financial Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.